Biotechnology / Medical Research

Page 1

Biotest says Bernhard Ehmer to become new CEO

Wednesday, 9 Jul 2014 12:12pm EDT

Biotest AG:Says Bernhard Ehmer to become new CEO of Biotest AG.Says as of Jan 1, 2015, Ehmer will take over role as CEO from Gregor Schulz, whose appointment will then end.

Capnia Inc appoints David O'Toole as Chief Financial Officer

Wednesday, 9 Jul 2014 07:00am EDT

Capnia Inc:Appoints David O'Toole as Chief Financial Officer.

Prima Biomed announces management change

Wednesday, 9 Jul 2014 03:59am EDT

Prima Biomed Ltd:Appoints Marc Voigt as Chief Executive Officer.Replaces Matthew Lehman who will step down from the Board but remain as an adviser.

Cerep changes name to Eurofins-Cerep; announces Chairman and CEO resignation

Tuesday, 8 Jul 2014 12:01pm EDT

Cerep SA:Chairman of Board and Chief Executive Officer Thierry Jean resigns from his post, effective by end of Sep. 2014.Cerep corporate name changed to Eurofins-Cerep by AGM of June 10.

Living Cell Technologies Ltd appoints Ken Taylor as chief executive

Monday, 7 Jul 2014 08:43pm EDT

Living Cell Technologies Ltd:Says that Ken Taylor has been appointed chief executive.Ken was appointed NTCELL Program director in Feb. and became acting chief executive in April.

Lexicon Pharmaceuticals Inc announces appointment of Lonnel Coats as President and Chief Executive Officer

Monday, 7 Jul 2014 04:15pm EDT

Lexicon Pharmaceuticals Inc:Announces that Lonnel Coats has been appointed president and chief executive officer effective July 7.

Raptor Pharmaceuticals Corp announces new CEO and President

Monday, 7 Jul 2014 04:00pm EDT

Raptor Pharmaceuticals Corp:Says that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating Officer, has been named President and CEO-designate effective immediately.Smith will succeed Christopher Starr, Ph.D., as Chief Executive Officer and will join the Board effective Jan. 01, 2015.

DiaMedica Inc appoints Rich Pilnik as Chairman

Monday, 7 Jul 2014 08:30am EDT

DiaMedica Inc:Says appointment of Richard Pilnik as Chairman of Board.Pilnik will replace Rick Pauls as Chairman.Pauls will continue as President & CEO and member of board.

Boston Therapeutics Inc announces resignation of President - Form 8-K

Thursday, 3 Jul 2014 04:01pm EDT

Boston Therapeutics Inc:Effective as of June 30, 2014, Kenneth A. Tassey, Jr. resigned as President and director.

AmpliPhi Biosciences Corp appoints David Bosher as interim chief financial officer - Form 8-K

Wednesday, 2 Jul 2014 12:56pm EDT

AmpliPhi Biosciences Corp:On June 30, company appointed David Bosher to serve as company’s interim chief financial officer.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.